Tumor‐infiltrating immune cells were assessed by mIHC using IHC markers for CD4 T cells, CD8 T cells, regulatory T cells, NK cells, M2 macrophages, and B cells (Figure 5B). This evidence concerns the gene CD4 and neoplasm.